Ferroptosis biomarkers predict tumor mutation burden's impact on prognosis in HER2-positive breast cancer

CONCLUSION: Our model helps guide the prognosis of HER2+ breast cancer patients, and its combination with the TMB can aid in more accurate assessment of patient prognosis and provide new ideas for further diagnosis and treatment.PMID:38576597 | PMC:PMC10989258 | DOI:10.5306/wjco.v15.i3.391

Source: Clinical Breast Cancer - April 5, 2024 Category: Cancer & Oncology Authors: Jin-Yu Shi Xin Che Rui Wen Si-Jia Hou Yu-Jia Xi Yi-Qian Feng Ling-Xiao Wang Shi-Jia Liu Wen-Hao Lv Ya-Fen Zhang Source Type: research